Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.
    Difference
    0.7%
    Check dated 2026-10-25T03:51:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T03:13:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T06:59:00.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the Record History, and the previous v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-20T01:54:03.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a minor metadata update to the page’s version history on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-30T00:42:29.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The history shows a new site revision (v3.6.5) was added and the previous revision (v3.6.4) was removed, reflecting a minor system update.
    Difference
    0.1%
    Check dated 2026-08-08T23:37:43.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.